Literature DB >> 27830532

Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.

Li Du1, Ying Zhang1, Yang Chen1, Jie Zhu1,2, Yi Yang3, Hong-Liang Zhang4,5.   

Abstract

Microglia are resident macrophage-like immune cells in the central nervous system (CNS) and play a vital role in both physiological and pathological conditions, including restoring the integrity of the CNS and promoting the progression of neurodegenerative disorders. Upon stimulation, microglia typically convert from a surveillant to an activated phenotype. The major function of microglia is to maintain homeostasis and normal function of the CNS, both during development and in response to CNS injury. Microglia regulate multiple aspects of inflammation, such as repair, cytotoxicity, regeneration, and immunosuppression due to their different kind of activation states or phenotypes. Although microglia are involved in almost all neurodegenerative disorders, the mechanisms for microglial activation and their potential contributions to neuronal degeneration remain a matter of intense debate. In inflammatory process of the CNS, polarized M1 microglia can produce proinflammatory cytokines, neurotoxic molecules, which contribute to dysfunction of neural network and promoting inflammation reaction, whereas polarized M2 microglia secrete antiinflammatory mediators and neurotrophic factors that are involved in restoring homeostasis. Modulation of microglial activation for therapeutic purposes might be realized via suppressing the deleterious effects of these cells, while simultaneously retaining their protective functions. Here, we summarize the functions of microglia and discuss dual role of microglia in neurodegenerative diseases as well as multiple sclerosis.

Entities:  

Keywords:  Inflammation; M1/M2 polarization; Microglia; Microglial activation; Neurodegenerative disorders

Mesh:

Substances:

Year:  2016        PMID: 27830532     DOI: 10.1007/s12035-016-0245-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  220 in total

1.  Ibuprofen, inflammation and Alzheimer disease.

Authors:  T Wyss-Coray; L Mucke
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

Review 2.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

3.  Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

Authors:  G P Lim; F Yang; T Chu; P Chen; W Beech; B Teter; T Tran; O Ubeda; K H Ashe; S A Frautschy; G M Cole
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

4.  Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.

Authors:  Oleg Butovsky; Mark P Jedrychowski; Ron Cialic; Susanne Krasemann; Gopal Murugaiyan; Zain Fanek; David J Greco; Pauline M Wu; Camille E Doykan; Olga Kiner; Robert J Lawson; Matthew P Frosch; Nathalie Pochet; Rachid El Fatimy; Anna M Krichevsky; Steven P Gygi; Hans Lassmann; James Berry; Merit E Cudkowicz; Howard L Weiner
Journal:  Ann Neurol       Date:  2014-11-27       Impact factor: 10.422

5.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 6.  Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.

Authors:  Joshua J Gagne; Melinda C Power
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

Review 7.  Proteins in microglial activation--inputs and outputs by subsets.

Authors:  Uwe-Karsten Hanisch
Journal:  Curr Protein Pept Sci       Date:  2013-02       Impact factor: 3.272

8.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Authors:  Laura Piccio; Cecilia Buonsanti; Marina Cella; Ilaria Tassi; Robert E Schmidt; Chiara Fenoglio; John Rinker; Robert T Naismith; Paola Panina-Bordignon; Nadia Passini; Daniela Galimberti; Elio Scarpini; Marco Colonna; Anne H Cross
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

9.  MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state.

Authors:  Reuben Saba; Shantel Gushue; Rhiannon L C H Huzarewich; Kathy Manguiat; Sarah Medina; Catherine Robertson; Stephanie A Booth
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.

Authors:  Denise C Fitzgerald; Zoë Fonseca-Kelly; Melissa L Cullimore; Pegah Safabakhsh; Christiaan J M Saris; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

View more
  84 in total

1.  Oxidative stress induces release of 2'-AMP from microglia.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2018-11-03       Impact factor: 3.252

2.  FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice.

Authors:  Qingzhi Wang; Jing Yuan; Zhanyang Yu; Li Lin; Yinghua Jiang; Zeyuan Cao; Pengwei Zhuang; Michael J Whalen; Bo Song; Xiao-Jie Wang; Xiaokun Li; Eng H Lo; Yuming Xu; Xiaoying Wang
Journal:  Mol Neurobiol       Date:  2017-07-15       Impact factor: 5.590

Review 3.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

Review 4.  Microglia: Housekeeper of the Central Nervous System.

Authors:  John Alimamy Kabba; Yazhou Xu; Handson Christian; Wenchen Ruan; Kitchen Chenai; Yun Xiang; Luyong Zhang; Juan M Saavedra; Tao Pang
Journal:  Cell Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.046

5.  Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain.

Authors:  Devon S Svoboda; M Inmaculada Barrasa; Jian Shu; Rosalie Rietjens; Shupei Zhang; Maya Mitalipova; Peter Berube; Dongdong Fu; Leonard D Shultz; George W Bell; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

Review 6.  Ethanol and Cytokines in the Central Nervous System.

Authors:  Marisa Roberto; Reesha R Patel; Michal Bajo
Journal:  Handb Exp Pharmacol       Date:  2018

7.  Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.

Authors:  Cao Chen; Xiao-Feng Xu; Ren-Qing Zhang; Yue Ma; Yan Lv; Jian-Le Li; Qiang Shi; Kang Xiao; Jing Sun; Xiao-Dong Yang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

8.  Transcriptome Sequencing Reveals Astrocytes as a Therapeutic Target in Heat-Stroke.

Authors:  Bing Niu; Tao Zhang; Huaiqiang Hu; Bingzhen Cao
Journal:  Neurosci Bull       Date:  2017-07-11       Impact factor: 5.203

9.  IL-4 and IL-10 promotes phagocytic activity of microglia by up-regulation of TREM2.

Authors:  Saini Yi; Xue Jiang; Xiaofang Tang; Yahui Li; Chenghong Xiao; Jinqiang Zhang; Tao Zhou
Journal:  Cytotechnology       Date:  2020-07-04       Impact factor: 2.058

10.  Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner.

Authors:  Sirena Soriano; Bridget Moffet; Evan Wicker; Sonia Villapol
Journal:  Cell Mol Neurobiol       Date:  2020-02-14       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.